Skip to main navigation
Close
Main navigation
Advocacy
Issue Overview
#MarkupMadness
#Rx4StateSavings
GDUFA/BsUFA User Fees
Build Back Better
State Legislation
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Meet Our Board
Social Commitment
Generic Medicines
Biosimilars
Careers
Contact Us
Stories
Events
Resources
All Resources
All Access Podcast
2021 Savings Report
2022 Voices of Access Report
Biosimilars Patient Resource Center
Supply Chain Blueprint
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action
Menu
AAM All Access Podcast
- Dan Leonard speaks with Mary Beth Powers, President and CEO of CMMB.
Learn More
Close
Breadcrumb
Home
Resources
Press Releases
Press Releases
Share
Press Release
Nov 19, 2021
| Rachel Schwartz
Association for Accessible Medicines Warns Build Back Better Act Threatens Patient Access
Press Release
Nov 12, 2021
| Rachel Schwartz
AAM Statement on the Nomination of Dr. Robert Califf to Lead FDA
Press Release
Nov 10, 2021
| Rachel Schwartz
Paula Witt Joins AAM as Senior Manager, State Government Affairs
Press Release
Nov 2, 2021
| Rachel Schwartz
AAM Opposes Latest Prescription Drug Reform Framework
Press Release
Oct 31, 2021
| Rachel Schwartz
Biosimilars Council Encourages Stakeholders, Advocates to Join #GlobalBiosimilarsWeek
Press Release
Oct 27, 2021
| Rachel Schwartz
Kenneth Westberry Joins AAM As Senior Manager, State Government Affairs
Press Release
Oct 6, 2021
| Rachel Schwartz
Christine Simmon Named Executive Vice President, Policy and Strategic Alliances for the Association for Accessible Medicines
Press Release
Sep 21, 2021
| Rachel Schwartz
Study Finds U.S. Generic and Biosimilar Savings Totaled A Record $338 Billion in 2020
Press Release
Sep 13, 2021
| Rachel Schwartz
Polly Webster Joins AAM As Vice President, Federal Affairs
Press Release
Sep 13, 2021
| Rachel Schwartz
Scott Kuzner Joins AAM As Senior Director, Sciences and Regulatory Affairs
Press Release
Sep 9, 2021
| Rachel Schwartz
AAM Statement on HHS 45-Day Plan to Lower the Cost of Prescription Drugs
Press Release
Aug 16, 2021
| Rachel Schwartz
AAM Calls for Increased Voluntary Licensing of Covid Vaccines to Increase Patient Access
Load More
Advocacy
Issue Overview
#MarkupMadness
#Rx4StateSavings
GDUFA/BsUFA User Fees
Build Back Better
State Legislation
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Meet Our Board
Social Commitment
Generic Medicines
Biosimilars
Careers
Contact Us
Stories
Events
GRx+Biosims 2022
Access! 2022
Resources
All Resources
All Access Podcast
2021 Savings Report
2022 Voices of Access Report
Biosimilars Patient Resource Center
Supply Chain Blueprint
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action